← Back to Search

Behavioural Intervention

Tailored for Vaping (SMART Trial)

N/A

Recruiting

Research Sponsored by Abramson Cancer Center at Penn Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up one week, two weeks, three weeks, and one month

Awards & highlights

SMART Trial Summary

This trial aims to reduce vaping among sexual and gender minority (SGM) youth aged 13-20 years by using tailored anti-vaping messages on social media. The researchers believe that these tailored messages

Who is the study for?

This trial is for sexual and gender minority (SGM) teens aged 13-20 who are interested in the effects of anti-vaping messages. The study aims to prevent vaping initiation by using social media as a platform for health communication, specifically tailored to SGM youth.Check my eligibility

What is being tested?

The effectiveness of culturally-tailored anti-vaping social media messages is being tested against non-tailored ones. The goal is to see if these specialized messages can more effectively prevent vaping among SGM teens.See study design

What are the potential side effects?

Since this trial involves exposure to anti-vaping messaging on social media rather than medical or pharmaceutical interventions, there are no direct physical side effects associated with participation.

SMART Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ one week, two weeks, three weeks, and one month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~one week, two weeks, three weeks, and one month

This trial's timeline: 3 weeks for screening, Varies for treatment, and one week, two weeks, three weeks, and one month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Susceptibility to vaping

Secondary outcome measures

Vaping initiation

SMART Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: TailoredExperimental Treatment1 Intervention

Participants in the tailored arm will receive SGM-tailored anti-vaping health messages delivered via text message

Group II: Non-TailoredActive Control1 Intervention

Participants in the non-tailored arm will receive non-tailored anti-vaping health messages delivered via text message

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Abramson Cancer Center at Penn MedicineLead Sponsor

387 Previous Clinical Trials

144,144 Total Patients Enrolled

University of FloridaOTHER

1,341 Previous Clinical Trials

714,146 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Which individuals meet the criteria to be eligible for enrollment in this research investigation?

"To be eligible for participation in this research study, individuals aged between 13 and 20 who have a history of vaping may qualify. The trial aims to enroll approximately 1500 potential participants."

Answered by AI

Are new patients currently being actively recruited for this clinical trial?

"Indeed, as outlined on clinicaltrials.gov, this current medical investigation is actively seeking individuals to enroll. Initially shared on 2/21/2024 and most recently revised on 3/6/2024, the trial aims to recruit 1500 participants at a single designated location."

Answered by AI

Is this research inviting individuals who are older than 40 years of age to participate?

"Prospective participants must be between 13 and 20 years old to meet the age requirements for this study."

Answered by AI

What is the total number of individuals participating in this clinical study?

"Yes, the details on clinicaltrials.gov confirm that this investigation is actively seeking participants. The trial was initially listed on February 21, 2024, with the most recent update made on March 6, 2024. A total of 1500 individuals are being sought from a single designated site."

Answered by AI

Recent research and studies

International Journal of Behavioral MedicineJournal

The Brief Resilience Scale: Assessing the Ability to Bounce Back

Smith, Bruce W., Jeanne Dalen, Kathryn Wiggins, Erin Tooley, Paulette Christopher, and Jennifer Bernard. 2008. “The Brief Resilience Scale: Assessing the Ability to Bounce Back”. International Journal of Behavioral Medicine. Springer Science and Business Media LLC. doi:10.1080/10705500802222972.

Journal of Sex ResearchJournal

Measuring Community Connectedness Among Diverse Sexual Minority Populations

Frost, David M., and Ilan H. Meyer. 2012. “Measuring Community Connectedness Among Diverse Sexual Minority Populations”. Journal of Sex Research. Informa UK Limited. doi:10.1080/00224499.2011.565427.

clinicaltrials.govStudy

Social Media Anti-Vaping Messages to Reduce ENDS Use Among Sexual and Gender Minority Teens

Andy Tan 2024. "Social Media Anti-Vaping Messages to Reduce ENDS Use Among Sexual and Gender Minority Teens". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06308081.

All > Paid Studies Baltimore > Philadelphia